COVID vaccine manufacturer Moderna’s CEO discusses the company’s Q3 earnings

Published 2022-08-07

Download video

Download video MP4 360p

Recommendations

49:19

Appalling vaccine injury
08:27

Salesforce is still the 'gold standard,' analyst says on AI concerns
1:37:12

Stocks Down & Bonds Up | Bloomberg Markets: The Close 05/30/2024
13:31

How the Pfizer-BioNTech COVID-19 vaccine was developed
05:20

Sticky inflation and soft consumer spending are reasons for worry, strategist says
05:19

Red Robin CEO discusses comeback plan amid inflation pressures
23:44

Elon Musk's Bionic Eyes Are Here.
03:22

How are Covid-19 vaccines being distributed across the world? - BBC News
2:34:52

Stock market today: Dow extends slide as Salesforce plunges, rate jitters rattle tech | May 30, 2024
12:16

🔥Журналісти у США злили рішення Байдена, Хто представлятиме США на саміті у ШВЕЙЦАРІЇ / Ворожко
16:33

ТЕРМІНОВО! Росіяни АТАКУВАЛИ Сумщину. Удар по центру міста. Чи є загроза НАСТУПУ на Суми?
03:33

Trump to consider Elon Musk for potential White House role: WSJ
05:32

Fed's Williams: Inflation doesn't need to be 'exactly at 2% to cut rates'
02:24

Covid-19 Vaccine Price: What are countries paying for the vaccine?
11:57

Putin's all ‘bluff and bluster’ as war concerns grow in Russia | Hamish de Bretton-Gordon
12:22

Nvidia CEO Jensen Huang talks blowout quarter, AI, inferencing, ongoing demand, and more
08:04

Why Trump's Wall Street donors may not care about guilty verdict
1:21:29

Sauna Benefits Deep Dive and Optimal Use with Dr. Rhonda Patrick & MedCram
02:26

Окупанти завдали ракетно-авіаційного удару по військових об’єктах і критичній інфраструктурі України
29:03

AMA #15: Fluoride Benefits/Risks & Vagus Nerve Stimulation

COVID vaccine manufacturer Moderna’s CEO discusses the company’s Q3 earnings

Download video

Download video MP4 360p

Appalling vaccine injury

Salesforce is still the 'gold standard,' analyst says on AI concerns

Stocks Down & Bonds Up | Bloomberg Markets: The Close 05/30/2024

How the Pfizer-BioNTech COVID-19 vaccine was developed

Sticky inflation and soft consumer spending are reasons for worry, strategist says

Red Robin CEO discusses comeback plan amid inflation pressures

Elon Musk's Bionic Eyes Are Here.

How are Covid-19 vaccines being distributed across the world? - BBC News

Stock market today: Dow extends slide as Salesforce plunges, rate jitters rattle tech | May 30, 2024

🔥Журналісти у США злили рішення Байдена, Хто представлятиме США на саміті у ШВЕЙЦАРІЇ / Ворожко

ТЕРМІНОВО! Росіяни АТАКУВАЛИ Сумщину. Удар по центру міста. Чи є загроза НАСТУПУ на Суми?

Trump to consider Elon Musk for potential White House role: WSJ

Fed's Williams: Inflation doesn't need to be 'exactly at 2% to cut rates'

Covid-19 Vaccine Price: What are countries paying for the vaccine?

Putin's all ‘bluff and bluster’ as war concerns grow in Russia | Hamish de Bretton-Gordon

Nvidia CEO Jensen Huang talks blowout quarter, AI, inferencing, ongoing demand, and more

Why Trump's Wall Street donors may not care about guilty verdict

Sauna Benefits Deep Dive and Optimal Use with Dr. Rhonda Patrick & MedCram

Окупанти завдали ракетно-авіаційного удару по військових об’єктах і критичній інфраструктурі України

AMA #15: Fluoride Benefits/Risks & Vagus Nerve Stimulation

Moderna CEO discusses COVID-19 risks, vaccine boosters, MRNA technology and more

Moderna CEO talks positive results from phase one of coronavirus vaccine trial

Moderna rises on vaccine sales forecast, eBay slips on earnings outlook, Alibaba falls

MRNA Stock | Moderna Inc Q3 2021 Earnings Call

Johnson & Johnson CFO on Q3 earnings, Covid vaccine booster

Thousands lining up for compensation, claiming the COVID vaccine made them sick | 7NEWS

Moderna Inc Q1 2022 Earnings Call

COVID-19 vaccines, variants and the coronavirus pandemic: Pharmaceutical CEOs discuss

MRNA Stock | Moderna Inc Q2 2021 Earnings Call

New Study: Moderna VS. Pfizer Vs. Novavax vs. Johnson & Johnson vs. COVID Infection

UIC Doctors Say Moderna COVID-19 Vaccine Trial May Have Information On Effectiveness By December

Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

Surging Moderna Stock Mints The Vaccine Maker’s Fifth Billionaire

FDA Commissioner Stephen Hahn and Novavax, Inc.'s Stanley Erck

Covid vaccine manufacturers update Congress on supply outlook

Pfizer and Moderna stocks rise on FDA approval of booster shots

Novavax files first COVID-19 vaccine authorization in UK

MRNA Stock | Moderna Annual Research and Development Day 2020 - Part I

Transforming Medicine | Stéphane Bancel | TEDxBeaconStreet

News Wrap: Moderna sues Pfizer and BioNTech, nuclear plant in Ukraine reconnected to grid